Intradermal Influenza Vaccination — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intradermal Influenza Vaccination — Stella

Home/Vaccine Reaction/

View on ClinicalTrials.gov

Recruiting

Back to Vaccine Reaction trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Church Street Research Unit, New Haven, Connecticut

Key details

Phase

Very early testing

Sponsor

Yale University

Collaborators

Chan Zuckerberg Initiative, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~249 participants

Started

January 2024

Primary completion

May 2026

Age range

18 Years – 40 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.